Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant: Midterm Outcomes Christian A. Bermudez, MD, Rodolfo V. Rocha, MD, Diana Zaldonis, MPH, BSN, Jay K. Bhama, MD, Maria M. Crespo, MD, Norihisa Shigemura, MD, PhD, Joseph M. Pilewski, MD, Penny L. Sappington, MD, Arthur J. Boujoukos, MD, Yoshiya Toyoda, MD, PhD The Annals of Thoracic Surgery Volume 92, Issue 4, Pages 1226-1232 (October 2011) DOI: 10.1016/j.athoracsur.2011.04.122 Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier 3-year survival in patients supported by extracorporeal membrane oxygenation before lung transplantation (ECMO pre-LTx) versus patients not supported by ECMO before lung transplantation (control). The Annals of Thoracic Surgery 2011 92, 1226-1232DOI: (10.1016/j.athoracsur.2011.04.122) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Kaplan-Meier 3-year survival in patients supported by extracorporeal membrane oxygneation (ECMO) before lung transplantation in the 1990s versus 2000s. The Annals of Thoracic Surgery 2011 92, 1226-1232DOI: (10.1016/j.athoracsur.2011.04.122) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier 2-year survival in patients supported by venovenous (VV) extracorporeal membrane oxygenation (ECMO) before lung transplantation versus patients supported by venoarterial (VA) ECMO before lung transplantation. The Annals of Thoracic Surgery 2011 92, 1226-1232DOI: (10.1016/j.athoracsur.2011.04.122) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions